K. A. Wall

发表

Demonstration of a remote surveillance system

J. V. Whichello, J. Brinch, D. L. Sorokowski, 1991 .

Synthesis of a Liposomal MUC1 Glycopeptide-Based Immunotherapeutic and Evaluation of the Effect of l-Rhamnose Targeting on Cellular Immune Responses.

Partha Karmakar, K. A. Wall, S. J. Sucheck, 2016, Bioconjugate chemistry.

Split Tolerance in a Novel Transgenic Model of Autoimmune Myasthenia Gravis1

K. A. Wall, J. Windle, B. Gelb, 2002, The Journal of Immunology.

Reply to Balasa and Sarvetnick.

K. A. Wall, A. Infante, K. Krolick, 2000, Immunology today.

A disease-related epitope of Torpedo acetylcholine receptor. Residues involved in I-Ab binding, self-nonself discrimination, and TCR antagonism.

K. A. Wall, A. Sette, S. Southwood, 1994, Journal of immunology.

Synthesis and immunological evaluation of a MUC1 glycopeptide incorporated into l-rhamnose displaying liposomes.

K. A. Wall, S. J. Sucheck, S. Sarkar, 2013, Bioconjugate chemistry.

Inhibitors of glycoprotein processing alter T-cell proliferative responses to antigen and to interleukin 2.

K. A. Wall, A. Elbein, J. Pierce, 1988, Proceedings of the National Academy of Sciences of the United States of America.

Characterization of the Murine Antigenic Determinant, Designated L3T4a, Recognized by Monoclonal Antibody GK 1.5: Expression of L3T4a by Functional T Cell Clones Appears to Correlate Primarily with Class II MHC Antigen‐Reactivity

K. A. Wall, P. Marrack, J. Kappler, 1983, Immunological reviews.

Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: similarity of L3T4 to the human Leu-3/T4 molecule.

K. A. Wall, M. Loken, A. Pierrès, 1983, Journal of immunology.

A monoclonal antibody against the type II isotype of beta-tubulin. Preparation of isotypically altered tubulin.

K. A. Wall, D. Cleveland, R. Luduena, 1988, The Journal of biological chemistry.

Synthesis of a single-molecule L-rhamnose-containing three-component vaccine and evaluation of antigenicity in the presence of anti-L-rhamnose antibodies.

K. A. Wall, S. J. Sucheck, S. Sarkar, 2010, Journal of the American Chemical Society.

Synthesis of α-L-rhamnosyl ceramide and evaluation of its binding with anti-rhamnose antibodies.

K. A. Wall, S. J. Sucheck, P. Karmakar, 2014, Bioorganic & medicinal chemistry.

Cloned T Lymphocytes and Monoclonal Antibodies as Probes for Cell Surface Molecules Active in T Cell‐Mediated Cytolysis

K. A. Wall, M. Loken, D. Lancki, 1982, Immunological reviews.

Development of a Bioconjugate Platform for Modifying the Immune Response of Autoreactive Cytotoxic T Lymphocytes Involved in Type 1 Diabetes.

K. A. Wall, S. J. Sucheck, M. Morran, 2019, Bioconjugate chemistry.

Preferential use of a T cell receptor V beta gene by acetylcholine receptor reactive T cells from myasthenia gravis-susceptible mice.

K. A. Wall, P. Thompson, A. Infante, 1992, Journal of immunology.

Inhibition of proliferation of MIs- and Ia-reactive cloned T cells by a monoclonal antibody against a determinant shared by I-A and I-E.

K. A. Wall, M. Loken, F. Fitch, 1983, Journal of immunology.

Liposomal Fc Domain Conjugated to a Cancer Vaccine Enhances Both Humoral and Cellular Immunity

K. A. Wall, S. J. Sucheck, Md Kamal Hossain, 2019, ACS omega.

Cell-surface modification with an iodinatible imidoester to enhance radiolabeling.

K. A. Wall, F. Fitch, K. Wall, 1985, Journal of immunological methods.

Augmenting Vaccine Immunogenicity through the Use of Natural Human Anti-rhamnose Antibodies

K. A. Wall, S. J. Sucheck, Md Kamal Hossain, 2018, ACS chemical biology.